On December 10, Xi'an Mace Topology Technology Co., Ltd. recently announced the completion of an angel round of financing of nearly 100 million yuan. The round was led by China Science and Technology Innovation Star, followed by Shuri Star and Zhengjing Capital, and Index Capital acted as the exclusive financial advisor. The financing will mainly be used for the construction of the company's Mianyang medical isotope production base and equipment installation and commissioning to achieve commercial supply of innovative alpha and beta nuclides such as Ac-225, Pb-212, and Cu-67 by the end of 2026.

On December 10, Xi'an Mace Topology Technology Co., Ltd. recently announced the completion of an angel round of financing of nearly 100 million yuan. The round was led by China Science and Technology Innovation Star, followed by Shuri Star and Zhengjing Capital, and Index Capital acted as the exclusive financial advisor. The financing will mainly be used for the construction of the company's Mianyang medical isotope production base and equipment installation and commissioning to achieve commercial supply of innovative alpha and beta nuclides such as Ac-225, Pb-212, and Cu-67 by the end of 2026.